This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Retinal Artery Occlusion or Retinal Vein Occlusion
and you are
between 20 and 35
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal vascular occlusive diseases. The purpose of the present study is to examine whether the autoregulation of retinal vessel diameters in normal persons change after remote ischemic conditioning.

Provided treatments

  • Procedure: Remote ischemic conditioning

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02898480. The sponsor of the trial is University of Aarhus and it is looking for 20 volunteers for the current phase.
Official trial title:
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning